Teladoc Health, Inc. (LON:0LDR)

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of GBP 1.02 billion. The enterprise value is 1.28 billion.

Market Cap	1.02B
Enterprise Value	1.28B

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	176.69M
Shares Outstanding	n/a
Shares Change (YoY)	+3.77%
Shares Change (QoQ)	+1.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	174.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.98
P/TBV Ratio	n/a
P/FCF Ratio	4.79
P/OCF Ratio	4.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 56.25, with an EV/FCF ratio of 6.01.

EV / Earnings	-8.45
EV / Sales	0.69
EV / EBITDA	56.25
EV / EBIT	n/a
EV / FCF	6.01

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.73.

Current Ratio	2.67
Quick Ratio	2.27
Debt / Equity	0.73
Debt / EBITDA	33.35
Debt / FCF	3.55
Interest Coverage	-8.07

Financial Efficiency

Return on equity (ROE) is -14.18% and return on invested capital (ROIC) is -4.13%.

Return on Equity (ROE)	-14.18%
Return on Assets (ROA)	-3.57%
Return on Invested Capital (ROIC)	-4.13%
Return on Capital Employed (ROCE)	-7.36%
Revenue Per Employee	366,720
Profits Per Employee	-29,911
Employee Count	5,500
Asset Turnover	0.79
Inventory Turnover	20.70

Taxes

Income Tax	-18.25M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.77% in the last 52 weeks. The beta is 1.10, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-3.77%
50-Day Moving Average	7.71
200-Day Moving Average	8.65
Relative Strength Index (RSI)	51.11
Average Volume (20 Days)	25,244

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.27

Income Statement

In the last 12 months, Teladoc Health had revenue of GBP 1.86 billion and -151.35 million in losses. Loss per share was -0.87.

Revenue	1.86B
Gross Profit	1.30B
Operating Income	-133.93M
Pretax Income	-169.60M
Net Income	-151.35M
EBITDA	13.78M
EBIT	-133.93M
Loss Per Share	-0.87

Balance Sheet

The company has 496.06 million in cash and 755.51 million in debt, giving a net cash position of -259.46 million.

Cash & Cash Equivalents	496.06M
Total Debt	755.51M
Net Cash	-259.46M
Net Cash Per Share	n/a
Equity (Book Value)	1.04B
Book Value Per Share	5.88
Working Capital	490.13M

Cash Flow

In the last 12 months, operating cash flow was 221.47 million and capital expenditures -8.56 million, giving a free cash flow of 212.92 million.

Operating Cash Flow	221.47M
Capital Expenditures	-8.56M
Free Cash Flow	212.92M
FCF Per Share	n/a

Margins

Gross margin is 70.26%, with operating and profit margins of -7.22% and -8.16%.

Gross Margin	70.26%
Operating Margin	-7.22%
Pretax Margin	-9.14%
Profit Margin	-8.16%
EBITDA Margin	0.74%
EBIT Margin	-7.22%
FCF Margin	11.47%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.77%
Shareholder Yield	n/a
Earnings Yield	-14.85%
FCF Yield	20.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.34
Piotroski F-Score	4